BrightAccountsProduction v1.0.0 v1.0.0 2025-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is to carry on the business or businesses of owning and operating pharmacies, including dispensary, counter sales including perfume, cosmetics, photographic services and other associated activity or service. 31 March 2026 NI057262 2025-12-31 NI057262 2024-12-31 NI057262 2023-12-31 NI057262 2025-01-01 2025-12-31 NI057262 2024-01-01 2024-12-31 NI057262 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 NI057262 uk-curr:PoundSterling 2025-01-01 2025-12-31 NI057262 uk-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 NI057262 uk-bus:FullAccounts 2025-01-01 2025-12-31 NI057262 uk-bus:Director1 2025-01-01 2025-12-31 NI057262 uk-bus:CompanySecretary1 2025-01-01 2025-12-31 NI057262 uk-bus:RegisteredOffice 2025-01-01 2025-12-31 NI057262 uk-bus:Agent1 2025-01-01 2025-12-31 NI057262 uk-core:ShareCapital 2025-12-31 NI057262 uk-core:ShareCapital 2024-12-31 NI057262 uk-core:RetainedEarningsAccumulatedLosses 2025-12-31 NI057262 uk-core:RetainedEarningsAccumulatedLosses 2024-12-31 NI057262 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-12-31 NI057262 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-12-31 NI057262 uk-bus:FRS102 2025-01-01 2025-12-31 NI057262 uk-core:Goodwill 2025-01-01 2025-12-31 NI057262 uk-core:LandBuildings 2025-01-01 2025-12-31 NI057262 uk-core:FurnitureFittingsToolsEquipment 2025-01-01 2025-12-31 NI057262 uk-core:MotorVehicles 2025-01-01 2025-12-31 NI057262 uk-core:Goodwill 2024-12-31 NI057262 uk-core:Goodwill 2025-12-31 NI057262 uk-core:CurrentFinancialInstruments 2025-12-31 NI057262 uk-core:CurrentFinancialInstruments 2024-12-31 NI057262 uk-core:WithinOneYear 2025-12-31 NI057262 uk-core:WithinOneYear 2024-12-31 NI057262 uk-core:WithinOneYear 2025-12-31 NI057262 uk-core:WithinOneYear 2024-12-31 NI057262 uk-core:WithinOneYear 2025-12-31 NI057262 uk-core:WithinOneYear 2024-12-31 NI057262 uk-core:AfterOneYear 2025-12-31 NI057262 uk-core:AfterOneYear 2024-12-31 NI057262 uk-core:BetweenOneTwoYears 2025-12-31 NI057262 uk-core:BetweenOneTwoYears 2024-12-31 NI057262 uk-core:OtherMiscellaneousReserve 2024-12-31 NI057262 uk-core:OtherMiscellaneousReserve 2025-01-01 2025-12-31 NI057262 uk-core:AcceleratedTaxDepreciationDeferredTax 2025-12-31 NI057262 uk-core:TaxLossesCarry-forwardsDeferredTax 2025-12-31 NI057262 uk-core:OtherDeferredTax 2025-12-31 NI057262 uk-core:RevaluationPropertyPlantEquipmentDeferredTax 2025-12-31 NI057262 uk-core:OtherMiscellaneousReserve 2025-12-31 NI057262 2025-01-01 2025-12-31 NI057262 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 xbrli:pure iso4217:GBP xbrli:shares

Company Registration Number: NI057262

MHD Healthcare Ltd

Unaudited Financial Statements

for the financial year ended 31 December 2025

MHD Healthcare Ltd

DIRECTOR AND OTHER INFORMATION

Director | Mr. Maurice Diamond
Company Secretary | Mrs. Carmel Diamond
Company Registration Number | NI057262
Registered Office | 16 Mount Charles
| Belfast
| BT7 1NZ
Business Address | 85 Old Town Road
| Castledawson
| BT45 8BZ
Accountants | Muldoon
| 16 Mount Charles
| Belfast
| BT7 1NZ
Bankers | First Trust Bank
| 8 High Street
| Omagh
| BT78 1BH

MHD Healthcare Ltd

Company Registration Number: NI057262

STATEMENT OF FINANCIAL POSITION

as at 31 December 2025

|  |  | 2025 |  | 2024
|  | Notes | £ |  | £
Non-Current Assets

Property, plant and equipment |  | 5 | 503,259 |  | 532,030
|  |  | ───────── |  | ─────────
Current Assets

Stocks |  | 6 | 158,000 |  | 158,830
Debtors |  | 7 | 109,281 |  | 138,777
Cash and cash equivalents |  |  | 82,051 |  | 204,321
|  |  | ───────── |  | ─────────
|  |  | 349,332 |  | 501,928
|  |  | ───────── |  | ─────────
Creditors: amounts falling due within one year |  | 8 | (685,811) |  | (801,348)
|  |  | ───────── |  | ─────────
Net Current Liabilities |  |  | (336,479) |  | (299,420)
|  |  | ───────── |  | ─────────
Total Assets less Current Liabilities |  |  | 166,780 |  | 232,610
Creditors:

amounts falling due after more than one year |  | 9 | - |  | (16,456)
Provisions for liabilities |  | 11 | (31,934) |  | (36,902)
|  |  | ───────── |  | ─────────
Net Assets |  |  | 134,846 |  | 179,252
|  |  | ═════════ |  | ═════════
Capital and Reserves

Called up share capital |  |  | 2 |  | 2
Retained earnings |  |  | 134,844 |  | 179,250
|  |  | ───────── |  | ─────────
Equity attributable to owners of the company |  |  | 134,846 |  | 179,252
|  |  | ═════════ |  | ═════════
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

The company has taken advantage of the exemption under section 444 not to file the Income Statement and Director's Report.

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Director and authorised for issue on 31 March 2026

________________________________ |  |  |  |  |
Mr. Maurice Diamond |  |  |  |  |
Director |  |  |  |  |

MHD Healthcare Ltd

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 December 2025

1. | General Information
| MHD Healthcare Ltd is a company limited by shares incorporated in Northern Ireland. 16 Mount Charles, Belfast, BT7 1NZ is the registered office. The company number is NI057262. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the year ended 31 December 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
| Turnover
| Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax. Revenue is recognised upon customer receipt.
| Goodwill
| Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Statement of Financial Position and amortised on a straight line basis over its economic useful life of 15 years, which is estimated to be the period during which benefits are expected to arise. On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
| Property, plant and equipment and depreciation
| Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
|  | Land and buildings freehold | - | 2% Straight Line
|  | Fixtures, fittings and equipment | - | 15% Reducing Balance
|  | Motor vehicles | - | 25% Reducing Balance
| Leasing and hire purchases
| Property, plant and equipment held under leasing and Hire Purchases arrangements which transfer substantially all the risks and rewards of ownership to the company are capitalised and included in the Statement of Financial Position at their cost or valuation, less depreciation. The corresponding commitments are recorded as liabilities. Payments in respect of these obligations are treated as consisting of capital and interest elements, with interest charged to the Income Statement.
| Stocks
| Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Borrowing costs
| Borrowing costs are recognised in profit or loss in the period in which they are incurred.
| Provisions
| Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
| Trade and other creditors
| Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
| Employee benefits
| The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund.
| Taxation and deferred taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Employees
| The average monthly number of employees, including director, during the financial year was:
|  | 2025 | 2024
|  | Number | Number
| Directors | 1 | 1
| Employees | 15 | 14
|  | ───────── | ─────────
|  | 16 | 15
|  | ═════════ | ═════════

4. | Intangible assets
|  | Goodwill | Total
|  | £ | £
| Cost
| At 1 January 2025 | 997,650 | 997,650
|  | ───────── | ─────────
| At 31 December 2025 | 997,650 | 997,650
|  | ───────── | ─────────
| Amortisation
| At 31 December 2025 | 997,650 | 997,650
|  | ───────── | ─────────
| Net book value
| At 31 December 2025 | - | -
|  | ═════════ | ═════════

5. | Property, plant and equipment
|  | Land and | Fixtures, | Motor | Total
|  | buildings | fittings and | vehicles |
|  | freehold | equipment |  |
|  | £ | £ | £ | £
| Cost
| At 1 January 2025 | 444,840 | 250,787 | 66,934 | 762,561
| Additions | - | 5,269 | - | 5,269
|  | ───────── | ───────── | ───────── | ─────────
| At 31 December 2025 | 444,840 | 256,056 | 66,934 | 767,830
|  | ───────── | ───────── | ───────── | ─────────
| Depreciation
| At 1 January 2025 | 60,419 | 128,955 | 41,157 | 230,531
| Charge for the financial year | 8,897 | 18,698 | 6,445 | 34,040
|  | ───────── | ───────── | ───────── | ─────────
| At 31 December 2025 | 69,316 | 147,653 | 47,602 | 264,571
|  | ───────── | ───────── | ───────── | ─────────
| Net book value
| At 31 December 2025 | 375,524 | 108,403 | 19,332 | 503,259
|  | ═════════ | ═════════ | ═════════ | ═════════
| At 31 December 2024 | 384,421 | 121,832 | 25,777 | 532,030
|  | ═════════ | ═════════ | ═════════ | ═════════

6. | Stocks | 2025 | 2024
|  | £ | £
| Finished goods and goods for resale | 158,000 | 158,830
|  | ═════════ | ═════════

7. | Debtors | 2025 | 2024
|  | £ | £
| Trade debtors | 98,745 | 90,280
| Other debtors | 1,487 | -
| Taxation (Note 10) | 9,049 | 48,497
|  | ───────── | ─────────
|  | 109,281 | 138,777
|  | ═════════ | ═════════

8. | Creditors | 2025 | 2024
| Amounts falling due within one year | £ | £
| Bank overdrafts | 3,926 | 4,250
| Bank loan | 12,314 | 37,172
| Net obligations under finance leases
| and hire purchase contracts | 5,407 | 7,209
| Trade creditors | 160,687 | 262,477
| Taxation (Note 10) | 10,442 | 25,204
| Director's current account | 451,766 | 455,559
| Other creditors | - | 4,176
| Accruals:
| Pension accrual | (573) | 462
| Other accruals | 41,842 | 4,839
|  | ───────── | ─────────
|  | 685,811 | 801,348
|  | ═════════ | ═════════

9. | Creditors | 2025 | 2024
| Amounts falling due after more than one year | £ | £
| Bank loan | - | 11,049
| Hire Purchase Loan | - | 5,407
|  | ───────── | ─────────
|  | - | 16,456
|  | ═════════ | ═════════
| Loans
| Repayable in one year or less, or on demand (Note 8) | 16,240 | 41,422
| Repayable between one and two years | - | 16,456
|  | ───────── | ─────────
|  | 16,240 | 57,878
|  | ═════════ | ═════════

10. | Taxation | 2025 | 2024
|  | £ | £
| Debtors:
| VAT | 9,049 | 48,497
|  | ═════════ | ═════════
| Creditors:
| Corporation tax | 1,999 | 17,055
| PAYE / NI | 8,443 | 8,149
|  | ───────── | ─────────
|  | 10,442 | 25,204
|  | ═════════ | ═════════

11. | Provisions for liabilities
| The amounts provided for deferred taxation are analysed below:
|  | Capital | Total | Total
|  | allowances |  |
|  |  | 2025 | 2024
|  | £ | £ | £
| At financial year start | 36,902 | 36,902 | 16,741
| Charged to profit and loss | (4,968) | (4,968) | 20,161
|  | ───────── | ───────── | ─────────
| At financial year end | 31,934 | 31,934 | 36,902
|  | ═════════ | ═════════ | ═════════